| Title : The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen - Henderson_2013_BMC.Neurol_13_188 |
| Author(s) : Henderson EJ , Lord SR , Close JC , Lawrence AD , Whone A , Ben-Shlomo Y |
| Ref : BMC Neurol , 13 :188 , 2013 |
| Abstract : Henderson_2013_BMC.Neurol_13_188 |
| ESTHER : Henderson_2013_BMC.Neurol_13_188 |
| PubMedSearch : Henderson_2013_BMC.Neurol_13_188 |
| PubMedID: 24299497 |
Henderson EJ, Lord SR, Close JC, Lawrence AD, Whone A, Ben-Shlomo Y (2013)
The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen
BMC Neurol
13 :188
Henderson EJ, Lord SR, Close JC, Lawrence AD, Whone A, Ben-Shlomo Y (2013)
BMC Neurol
13 :188